Timothy Juday

Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines

Diana T. Amari, Timothy Juday, Feride Frech et al. · BMC Geriatrics · 2022 · 50 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States

Feride Frech, Timothy Juday, Yingying Ding et al. · The Journal of Prevention of Alzheimer s Disease · 2024 · 22 citations · Full text

Medicine, Economics, Pharmacoeconomics +17

Lemborexant for the Treatment of Insomnia

Leslie Citrome, Timothy Juday, Feride Ferch et al. · The Journal of Clinical Psychiatry · 2021 · 21 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Fall Risk, Healthcare Resource Use, and Costs Among Adult Patients in the United States Treated for Insomnia with Zolpidem, Trazodone, or Benzodiazepines: A Retrospective Cohort Study

Diana T. Amari, Timothy Juday, Feride Frech et al. · Advances in Therapy · 2022 · 17 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +15

Adherence, persistence, healthcare utilization, and cost benefits of guideline-recommended hepatitis B pharmacotherapy

Steven‐Huy B. Han, Wuhua Jing, Edward Mena et al. · Journal of Medical Economics · 2012 · 14 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17